➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Dow
Colorcon
Moodys
Boehringer Ingelheim

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Wyeth LLC v. Sun Pharmaceutical Industries, Inc. (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Wyeth LLC v. Sun Pharmaceutical Industries, Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-12-23
Court District Court, D. Delaware Date Terminated 2019-11-01
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Defendant Referred To
Parties WYETH LLC
Patents 6,596,746; 7,015,018; 7,125,875; 7,417,148; 7,767,678; 7,919,625; 7,989,494; 8,013,002; 8,039,010; 8,063,015; 9,081,016; 9,109,020
Attorneys Jeffrey Martin
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Wyeth LLC v. Sun Pharmaceutical Industries, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Wyeth LLC v. Sun Pharmaceutical Industries, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Wyeth LLC v. Sun Pharmaceutical Industries, Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 19 ). Date of Expiration of Patent: 7,767,678 - November 23, 2026 and 7,417,148 - January 23, 2026.Thirty… Amended Supplemental information for patent cases involving an Abbreviated New Drug Application…2016 1 November 2019 1:16-cv-01305 830 Patent Defendant District Court, D. External link to document
0000-00-00 20 2016 (Sun Defendants). Date of Expiration of Patent: 7,767,678 - November 23, 2026.Thirty Month Stay Deadline… Amended Supplemental information for patent cases involving an Abbreviated New Drug Application…2016 1 November 2019 1:16-cv-01305 830 Patent Defendant District Court, D. External link to document
0000-00-00 205 Notice of Service ., Ph.D. Regarding Infringement of U.S. Patent Nos. 7,417,148 and 7,919,625 by Sun Pharmaceutical Industries…J. Chyall, Ph.D. Regarding Infringement of U.S. Patent No. 7,767,678 by Sun Pharmaceutical Industries …2016 1 November 2019 1:16-cv-01305 830 Patent Defendant District Court, D. External link to document
0000-00-00 206 Notice of Service M.D., Ph.D. Regarding Infringement of U.S. Patent No. 7,417,148 by Alembic Pharmaceuticals, Ltd. and Alembic…2016 1 November 2019 1:16-cv-01305 830 Patent Defendant District Court, D. External link to document
0000-00-00 210 Notice of Service , Ph.D., Regarding the Validity of U.S. Patent Nos. 7,417,148 and 7,919,625, (2) Responsive Expert Report…, Ph.D., Regarding the Validity of U.S. Patent Nos. 7,417,148 and 7,919,625, (3) Responsive Expert Report…, Ph.D., Regarding the Validity of U.S. Patent Nos. 7,417,148 and 7,919,625 and (5) Expert Report of Leonard…L. Trout, Ph.D., Regarding the Validity of U.S. Patent 7,919,625, (4) Expert Report of Neil Shah, M.D.… Ph.D., Regarding the Validity of United States Patent 7,767,678 filed by PF Prism C.V., Pfizer PFE Ireland External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Baxter
McKesson
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.